Krystal Biotech, Inc. (KRYS)

270.26 -2.39 (-0.88%) USD  |  NASDAQ  |  Feb 12, 16:00
270.10 -0.16 (-0.06%) After-Hours: 20:00
More

Krystal Biotech Free Cash Flow : 165.59M for Sept. 30, 2025

Free Cash Flow Chart

View Free Cash Flow for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Amicus Therapeutics, Inc. 9.691M
DexCom, Inc. 1.062B
Alkermes Plc 490.87M
Regeneron Pharmaceuticals, Inc. 3.765B
Alnylam Pharmaceuticals, Inc. 221.36M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 39.66M
Cash from Investing (Quarterly) -4.286M
Cash from Financing (Quarterly) 3.709M
Free Cash Flow Per Share (Quarterly) 1.272
Free Cash Flow to Equity (Quarterly) 38.12M
Free Cash Flow to Firm (Quarterly) 37.96M
Free Cash Flow Yield 2.05%